Evolent Health, Inc $EVH Shares Acquired by Peregrine Capital Management LLC

Peregrine Capital Management LLC grew its holdings in Evolent Health, Inc (NYSE:EVH) by 34.9% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 703,038 shares of the technology company’s stock after buying an additional 181,980 shares during the period. Peregrine Capital Management LLC’s holdings in Evolent Health were worth $7,916,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also modified their holdings of the business. Nisa Investment Advisors LLC raised its position in shares of Evolent Health by 88.0% in the second quarter. Nisa Investment Advisors LLC now owns 2,551 shares of the technology company’s stock valued at $29,000 after buying an additional 1,194 shares during the last quarter. Kornitzer Capital Management Inc. KS acquired a new stake in Evolent Health during the second quarter worth about $1,133,000. Values First Advisors Inc. increased its position in Evolent Health by 18.6% during the second quarter. Values First Advisors Inc. now owns 55,090 shares of the technology company’s stock worth $620,000 after purchasing an additional 8,646 shares during the last quarter. Nordea Investment Management AB increased its position in Evolent Health by 3.3% during the second quarter. Nordea Investment Management AB now owns 130,103 shares of the technology company’s stock worth $1,462,000 after purchasing an additional 4,101 shares during the last quarter. Finally, Vanguard Personalized Indexing Management LLC acquired a new stake in Evolent Health during the second quarter worth about $198,000.

Evolent Health Trading Down 2.1%

Shares of EVH stock opened at $7.65 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.01 and a quick ratio of 1.01. The firm has a market cap of $898.36 million, a PE ratio of -4.75 and a beta of 0.66. The company has a 50-day moving average of $8.68 and a two-hundred day moving average of $9.22. Evolent Health, Inc has a 1-year low of $7.06 and a 1-year high of $25.22.

Evolent Health (NYSE:EVH) last announced its earnings results on Tuesday, June 4th. The technology company reported $0.21 earnings per share for the quarter. The company had revenue of $427.70 million during the quarter. Evolent Health had a negative net margin of 5.94% and a positive return on equity of 1.83%. On average, analysts predict that Evolent Health, Inc will post 0.08 EPS for the current year.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the stock. Canaccord Genuity Group restated a “buy” rating and set a $16.00 price objective on shares of Evolent Health in a research report on Tuesday, September 9th. BTIG Research restated a “buy” rating and set a $20.00 price objective on shares of Evolent Health in a research report on Tuesday, September 30th. Piper Sandler raised their price objective on shares of Evolent Health from $16.00 to $18.00 and gave the stock an “overweight” rating in a research report on Thursday, August 28th. Zacks Research cut shares of Evolent Health from a “hold” rating to a “strong sell” rating in a research report on Friday, October 10th. Finally, Truist Financial increased their target price on shares of Evolent Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research note on Thursday, July 17th. Twelve equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $15.85.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.